Home Other Building Blocks Piperidine-1-carboxamide

Piperidine-1-carboxamide

CAS No.:
2158-03-4
Catalog Number:
AG003EN3
Molecular Formula:
C6H12N2O
Molecular Weight:
128.1723
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG003EN3
Chemical Name:
Piperidine-1-carboxamide
CAS Number:
2158-03-4
Molecular Formula:
C6H12N2O
Molecular Weight:
128.1723
MDL Number:
MFCD00075305
IUPAC Name:
piperidine-1-carboxamide
InChI:
InChI=1S/C6H12N2O/c7-6(9)8-4-2-1-3-5-8/h1-5H2,(H2,7,9)
InChI Key:
JSPCTNUQYWIIOT-UHFFFAOYSA-N
SMILES:
NC(=O)N1CCCCC1
EC Number:
218-476-5
NSC Number:
108219
Properties
Complexity:
108  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
128.095g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
128.175g/mol
Monoisotopic Mass:
128.095g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
46.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.1  
Literature
Title Journal
Behavioral and neurochemical profile of some novel phenacyl based isonipecotamide derivatives. Pakistan journal of pharmaceutical sciences 20121001
Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors. Journal of medicinal chemistry 20120927
A β-tryptase inhibitor with a tropanylamide scaffold to improve in vitro stability and to lower hERG channel binding affinity. Bioorganic & medicinal chemistry letters 20120215
Development of Metarhizium anisopliae and Beauveria bassiana formulations for control of malaria mosquito larvae. Parasites & vectors 20110101
New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis. PloS one 20110101
A conformationally constrained inhibitor with an enhanced potency for β-tryptase and stability against semicarbazide-sensitive amine oxidase (SSAO). Bioorganic & medicinal chemistry letters 20101115
Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74. Biochemical and biophysical research communications 20100101
Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent. Journal of medicinal chemistry 20091224
Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition. Bioorganic & medicinal chemistry letters 20090801
Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilities. Bioorganic & medicinal chemistry letters 20090801
Synthesis and structure-activity relationship of novel diarylpyrazole imide analogues as CB1 cannabinoid receptor ligands. Bioorganic & medicinal chemistry 20090415
The design and discovery of novel amide CCR5 antagonists. Bioorganic & medicinal chemistry letters 20090215
Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting. Therapeutics and clinical risk management 20090101
1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor. Bioorganic & medicinal chemistry 20080315
Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteries. The Journal of pharmacology and experimental therapeutics 20080301
Methoxy- and fluorine-substituted analogs of O-1302: synthesis and in vitro binding affinity for the CB1 cannabinoid receptor. Chemical & pharmaceutical bulletin 20070801
Piperidine amides as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors. Bioorganic & medicinal chemistry letters 20070615
Pharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteries. Naunyn-Schmiedeberg's archives of pharmacology 20070301
Enantioselective strecker reaction of phosphinoyl ketoimines catalyzed by in situ prepared chiral N,N'-dioxides. The Journal of organic chemistry 20070105
Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1. Molecular pharmacology 20061201
A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptors. Molecular pharmacology 20050101
Noncompetitive antagonism of BIBN4096BS on CGRP-induced responses in human subcutaneous arteries. British journal of pharmacology 20041201
Structure activity relationship by NMR and by computer: a comparative study. Journal of the American Chemical Society 20020918
GC/MS investigations of the minor constituents of Piper guineense stem. Die Pharmazie 20020901
A piperidine amide extracted from Piper longum L. fruit shows activity against Aedes aegypti mosquito larvae. Journal of agricultural and food chemistry 20020619
Tandem mass spectrum of a growth hormone secretagogue: amide bond cleavage and resultant gas-phase rearrangement. Journal of the American Society for Mass Spectrometry 20020401
Properties